R&D

At New Vision Solutions, we have our own in-house laboratory with branches extending from South America through Eastern Europe and into Central Asia, employing more than 400 pharmaceutical specialists. We invest a full 15% of our annual gross revenue into R&D. In the quest for new products we cooperate with accomplished scientists and doctors from all over the world, with universities and healthcare centers, and with biotechnological companies and research centers. We pursue every opportunity to expand our knowledge base and apply it to the benefit of people.

Our in-house, internationally acclaimed R&D laboratory – extending from South America, through Eastern Europe and into Central Asia is something of our company’s calling card:

  • with more than 400 specialists involved daily in the search for innovative treatments
  • with 15% of the company’s gross revenue is annually invested into R&D

And yet we hold that even this level of investment is insufficient. In the search for ever newer and more effective medications, we cooperate with accomplished scientists and doctors from all over the world, with universities and healthcare centers, and with biotechnological companies and research centers. We pursue every opportunity to expand our knowledge base and apply it to the benefit of people. This comprehensive approach to R&D helps reduce significantly the time spent on developing new, effective medical treatments.

In pursuit of this goal we:

– set our R&D priorities by applying quality analysis of the most urgent needs within the healthcare system;
– emphasize efficient interaction between in-house and outsourced research;
– employ an integrated approach to product development, collaborating with academic and medical communities in pursuit of superior trial results and effective treatment selection;
identify more effective research projects in the early stages and finance them more aggressively.